CYRX News and Press, CryoPort Inc. From 10/03/23

2023-10-03 09:39:55 ET Summary Cryoport has experienced a decline in revenue and worsening bottom line results over the past year. The company's stock has fallen 30.6% since May and 64.2% since July 2022. Despite potential in the life sciences market, Cryoport needs to show pr...

Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award PR Newswire Company Named "Best Cell & Gene Therapy Supplier – Cryogenic Storage" NA...

2023-09-12 13:00:07 ET More on Industrial Select Sector SPDR ETF Seeking Alpha’s Quant Rating on Industrial Select Sector SPDR ETF Dividend scorecard for Industrial Select Sector SPDR ETF A Rising Interest Rate Freight Train Is Coming For The Economy X...

2023-08-17 19:25:18 ET More on CryoPort Cryoport, Inc. ( CYRX ) Q2 2023 Earnings Call Transcript Cryoport: Revising To Hold After Major Changes To Forecasts, Sentiment Cryoport: A Strong Player In Cold-Chain Logistics With Solid Growth Prospects Cryoport'...

2023-08-10 08:25:22 ET Galera Therapeutics ( GRTX ) -82% . Origin Materials ( ORGN ) -57% after Q2 earning release . Organogenesis Holdings ( ORGO ) -32% after Q2 earning release . Renovaro Biosciences ( RENB ) -23% . Wolverine World...

2023-08-09 22:42:02 ET Cryoport, Inc. (CYRX) Q2 2023 Earnings Conference Call August 9, 2023 17:00 ET Corporate Participants Todd Fromer - Investor Relations, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Finan...

2023-08-09 16:18:38 ET CryoPort press release ( NASDAQ: CYRX ): Q2 GAAP EPS of -$0.42 misses by $0.17 . Revenue of $57.02M (-11.2% Y/Y) beats by $0.09M . Cryoport's revenue for the full year 2023 is expected to be in the range of $233 - $243 million $233.9...

Cryoport Reports Second Quarter 2023 Financial Results PR Newswire Second quarter revenue of $57 million , in line with previously announced preliminary results Clinical trials supported by Cryoport increased to a record 668 global clinical trials by quarter end;...

Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023 PR Newswire NASHVILLE, Tenn. , Aug. 2, 2023 /PRNewswire/ -- Cry oport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and s...

2023-07-28 09:00:00 ET Summary Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The portfolio gained +17.4% (17.2% net) for the second quarter of 2023 compared to a +4.8% return for the Russell M...